Results 111 to 120 of about 305,335 (274)

Kommerzielle Open Access Publishing-Geschäftsmodelle auf dem Prüfstand: ökonomische Zwischenbilanz der

open access: yesGMS Medizin – Bibliothek – Information, 2006
Librarians amongst many others point towards Open Access Publishing as being the loophole in the current library and journal crisis. However, Open Access Publishing could entail higher costs for the university as a whole even though spendings for ...
Bauer, Bruno
doaj  

Open access: Māori perspectives on publishing

open access: yesInformation Research: An International Electronic Journal
Introduction. This short paper presents the results of a project that looked at Māori researchers’ attitudes to open access publishing. It presents an overview of their engagement with green and gold publishing options, including barriers and challenges
Spencer Lilley
doaj   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

OPERAS: bringing the long tail of Social Sciences and Humanities into Open Science

open access: yesJLIS.it, 2019
The paper will present OPERAS, a comprehensive infrastructure aimed at providing a pan-European infrastructure to rethink and reshape publishing, discovery and dissemination addressing the specificity and the critical issues of Social Sciences and ...
Elena Giglia
doaj   +2 more sources

Principles of Best Practice and Transparency in Scholarly Publishing ver. 4: a Korean translation [PDF]

open access: yesThe Ewha Medical Journal
The Committee on Publication Ethics, DOAJ, the Open Access Scholarly Publishing Association, the World Association of Medical Editors
doaj   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Behavioral Reluctance in Adopting Open Access Publishing: Insights From a Goal-Directed Perspective. [PDF]

open access: yesFront Psychol, 2021
Köster M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy